<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib6">
 <label>6</label>
 <element-citation publication-type="journal" id="sref6">
  <person-group person-group-type="author">
   <name>
    <surname>Cohen</surname>
    <given-names>E.E.W.</given-names>
   </name>
   <name>
    <surname>Karrison</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kocherginsky</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Agulnik</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mittal</surname>
    <given-names>B.B.</given-names>
   </name>
  </person-group>
  <article-title>DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN)</article-title>
  <source>J Clin Oncol</source>
  <volume>30</volume>
  <issue>suppl</issue>
  <year>2012</year>
  <fpage>5500</fpage>
 </element-citation>
</ref>
